Respirable Formulations
Respirable Formulations is a specialized pharmaceutical formulation designed for pulmonary delivery, distinguished by its optimization of physicochemical properties—such as particle size, morphology, and aerodynamic behavior—to enable efficient deposition in the lower respiratory tract upon inhalation.
27
Publications
1.4K
Citations
130
Authors
66
Institutions
Publications per year
2017–2026
6
Parents
27
Dieter Vandenheuvel, Abhishek Singh, Katrien Vandersteegen et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2013 · 135 citations
Surinder S. Birring, Marlies Wijsenbeek, Sanjay Agrawal et al. · The Lancet Respiratory Medicine · 2017 · 119 citations · Full text
Laleh Golshahi, Karlene H. Lynch, Jonathan J. Dennis et al. · Journal of Applied Microbiology · 2010 · 115 citations
1–5 of 27
130
3
h-index
3
h-index
2
h-index
2
h-index
University of North Carolina at Chapel Hill, United States
2 publications · 85 citations
2
h-index
1–5 of 130
66
King's College London
London, United Kingdom
3 h-index
6 publications
302 citations

University of Parma
Parma, Italy
3 h-index
17 publications
555 citations
University of North Carolina at Chapel Hill
Chapel Hill, United States
2 h-index
3 publications
140 citations

Research Triangle Park Foundation
Durham, United States
2 h-index
3 publications
115 citations

University of Alberta
Edmonton, Canada
2 h-index
9 publications
1.1K citations
University of Technology Sydney
Sydney, Australia
2 h-index
2 publications
73 citations
GlaxoSmithKline (United States)
Philadelphia, United States
2 h-index
3 publications
115 citations

The University of Sydney
Sydney, Australia
2 h-index
6 publications
212 citations
1–8 of 66
3 publications · 121 citations
3
h-index
2 publications · 62 citations
2
h-index
EJPB · 2 publications · 208 citations
2
h-index
2 publications · 157 citations
2
h-index
1 publications · 60 citations
1
h-index
1–5